Scientists test 'Living Vaccine' that trains immune system to hunt cancer
NCT ID NCT05631899
Summary
This early-stage trial is testing a personalized cancer vaccine made from a patient's own immune cells. The cells are engineered to target two specific markers found on some advanced solid tumors. The vaccine is given alongside standard immunotherapy drugs to see if it's safe and can help control the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR, ADULT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Biotherapeutic Department of Chinsese PLA Gereral Hospital
Beijing, Beijing Municipality, 100853, China
Conditions
Explore the condition pages connected to this study.